Revenue segments as reported by the company.

Cannabis revenue

Distribution revenue

Beverage alcohol revenue

Wellness revenue

Adult-use

Canada - Medical

International - Medical

Bulk

Hemp

Revenue Segments

Gross Profit, Operating Income, and Net Income as a percentage of Revenue

Gross Margin

Operating Margin

Profit Margin

Margins

An operating expense is an expense a business incurs through its normal business operations. Often abbreviated as OPEX.

Impairment of Assets

Litigation settlement

Transaction costs

Change in fair value of contingent consideration

Restructuring costs

Other than temporary change in fair value of convertible notes receivable

Operating Expenses

Year over year growth in Revenue and Operating Expenses.

Revenue Y/Y

OpEx Y/Y

Growth

Shares outstanding refer to a company's stock currently held by all its shareholders, including share blocks held by institutional investors and restricted shares owned by the company's officers and insiders.

Outstanding Shares

Market Cap

Also known as Price/Sales Ratio. Calculated using Average market cap for the quarter / Annualized quarterly revenue.

Revenue Multiple

Tilray Brands

Tilray Brands, Inc. is a global cannabis-lifestyle and consumer packaged goods company with operations in Canada, the United States, Europe, Australia, and Latin America. The firm is focused on medical cannabis research and the cultivation, processing, and distribution of cannabis products worldwide. Its products include dried cannabis and cannabis extracts. It operates through the following segments: Cannabis and Hemp. The Cannabis segment consists of adult-use, medical and bulk sales of cannabis under regulated licenses and sold to retail, wholesale, pharmacy, government, and direct to patient. The Hemp segment consists of hemp seed, hemp foods, and broad spectrum hemp extract containing CBD, which are sold in an unlicensed operation and sold to retail, wholesale and direct to consumers. The company was founded on January 24, 2018 and is headquartered in Leamington, Canada.

Earnings data Q1 2021

Earnings data Q4 2021

Earnings data Q1 2022

Earnings data Q2 2022

Earnings data Q3 2022

Earnings data Q4 2022

Earnings data Q1 2023

Earnings data Q2 2023

Earnings data Q3 2023

Earnings data Q4 2023

Earnings data Q1 2024

Earnings data Q2 2024

Earnings data Q3 2024

Earnings data Q4 2024

Earnings data Q1 2025

Earnings data Q2 2025

Tilray Brands reports record revenue and optimistic outlook for 2025

Tilray Brands achieved remarkable financial performance in Q4 2024, driven by strategic acquisitions and a focus on innovation. Despite challenges like price compression, the company remains optimistic about future growth opportunities. Tilray's commitment to quality products and innovation positions it well for continued success in the market.

Tilray Brands reports record Q1 revenue growth and global expansion

Tilray Brands delivered a robust performance in Q1 2025, showcasing strong revenue growth, margin improvement, and strategic expansion across its diversified product portfolio.
While facing challenges in a competitive landscape and evolving regulatory environment, Tilray's financial strength, international growth initiatives, and focus on innovation position it well for future success.
By capitalizing on opportunities in wellness products, expanding into new beverage categories, and leveraging strategic partnerships, Tilray is poised for continued growth and market leadership.

Revenue

Cost of revenue

Gross profit

Operating expenses

SG&A

Other

Operating income

EBITDA

Net income

Earnings per share

Total assets

Current assets

Cash & equivalents

Receivables

Inventory

Non-current assets

Net PPE

Intangibles

Total liabilities

Current liabilities

Short term debt

Income tax payable

Non-current liabilities

Long-term debt

Total equity

Stockholders equity

Minority interest

Total liabilities & equity

Total debt

Net debt

Book value per share

Cash from operations

Funds from operations

Change in working capital

Cash from investing

Capital expenditure

Purchase/sale of investments

Purchase/sale of business

Other sources

Cash from financing

Change in stock

Change in debt

Cash dividends paid

Cash from other sources

Net change in cash

Free cash flow

Tilray Brands, Inc. is a global cannabis-lifestyle and consumer packaged goods company, which focuses on medical cannabis research and the cultivation, processing, and distribution of cannabis products worldwide. It operates through the followings segments: Cannabis Business, Distribution Business, Beverage Alcohol Business, and Wellness Business. The Cannabis Business segment focuses on cultivation, production, distribution, and sale of both medical and adult-use cannabis products. The Distribution Business segment is involved in purchase, resale, and distribution of pharmaceutical and wellness products. The Beverage Alcohol Business segment refers to the production, marketing, and sale of beverages. The Wellness Business segment represents the production, marketing, and distribution of hemp-based food and other wellness products. The company was founded on January 24, 2018 and is headquartered in Leamington, Canada.

Aurora Cannabis

HEXO Corp

These stocks won't have investors seeing green.

3 Marijuana Stocks to Avoid Like the Plague in March

The cannabis company appears to have backed out of its arrangement to buy 420 Investments.

Tilray Sued Over Dispensary Acquistion Deal

Cronos Group

Worries about the global supply chain are sinking these five Canadian pot stocks today.

Why Aurora Cannabis, Cronos Group, HEXO, OrganiGram Holdings, and Tilray Are Getting Hammered Today

CannTrust Holdings

Pessimism continues to be unwavering for these cannabis companies.

Downside Bets on These 3 Pot Stocks Rocketed Higher in January

In a note to investors Monday, Cowen analyst Vivien Azer wrote that Canada’s cannabis sales in 2020 would reach just $3.2 billion, nearly a third lower than her original estimate of around $4.6 billion.

Why Tilray Stock Continues to Struggle

Benjamin Netanyahu also aims to expunge the criminal records of those persecuted for marijuana offenses.

Israel's Prime Minister Says Country Could Follow Canadian Model of Pot Legalization

An analyst downgrade weighed on the Canadian cannabis producer's shares.

Why Tilray Stock Sank Today

SNDL Inc.

One of the banks that's most enthusiastic about the marijuana industry just cut its ratings on some of the largest producers in North America.

Cowen Downgrades 3 Canadian Cannabis Stocks

Why marijuana stocks are tanking Monday may be a bit counterintuitive. After all, with major U.S.

Why Cronos and Tilray Have Crumbled

Cannabis stocks fell as Cowen downgraded Aurora Cannabis and Tilray but kept Canopy Growth as its only "outperform" pot stock.
The post Why This Is The Only Marijuana Stock A Top Pot Analyst Still Rates As A Buy appeared first on Investor's Business Daily.

Why This Is The Only Marijuana Stock A Top Pot Analyst Still Rates As A Buy

Cowen downgraded Aurora Cannabis Inc. ACB, -0.60% ACB, -0.90% , Tilray Inc. TLRY, +0.68% and Sundial Growers Inc.

Aurora Cannabis, Tilray and Sundial stocks slide premarket as Cowen downgrades all three

Nasdaq

OrganiGram Holdings Inc.

New Leaf Data Services is compiling the numbers from cannabis business entities in Canada.

Nasdaq Adds Marijuana Price Indexes to Its Platform

Despite their miserable performance, marijuana stocks were in high demand by asset managers in Q4.

Surprise! Billionaire Money Managers Bought These 4 Pot Stocks in the Fourth Quarter

Canopy Growth

MedMen Enterprises Inc.

The cannabis industry has a major cash problem.

10 Pot Stocks That Could Run Out of Money in 10 Months (or Less)

When it comes to cans, THC levels are likely to be lower than what's on the label.

Aluminum Cans May Reduce the Potency of Cannabis Beverages

Aphria

It's a question that needs to be asked now more than ever.

Should Investors Avoid Large-Cap Pot Stocks Altogether?

Scotts Miracle-Gro

After a brutal year in 2019, cannabis stocks are off to another rough start so far in 2020.

7 Cannabis Stocks To Buy, Sell And Hold

The green rush has officially hit the growing pains stage.

4 Brand-Name Cannabis Stocks Laying Off Workers

Investors are bracing for more job cuts and writedowns at Canadian cannabis producers before the industry stabilizes and becomes profitable, after two of the biggest weed companies, Aurora Cannabis  and Tilray  announced cost reductions this week.

More pain in store for Canadian marijuana companies after Aurora Cannabis, Tilray cut jobs

With so many cannabis stocks to choose from, which ones have what it takes to break out from the crowd? Here are three with strong potential.

3 Cannabis Stocks Ready to Break Away From the Crowd

Tilray: 10% Cut Is A Start

The trend of layoffs in the cannabis industry, which started in 2019, has done nothing but accelerate in 2020 with:

Tilray, Aurora Cannabis Layoffs May Signal Industrywide Problem

I wouldn't call TLRY the hottest cannabis stock on the market, but when you look at the charts, Tilray stock is improving.
The post Pass On Tilray Stock If You’re Looking for Cannabis Plays appeared first on InvestorPlace.

Pass On Tilray Stock If You’re Looking for Cannabis Plays

One of Canada's largest cannabis producers is taking a big step back.

Tilray Is Restructuring and Laying Off Staff

Canada-based weed producer Tilray Inc. TLRY, +5.16% said late Tuesday that it was restructuring the company, which included laying off roughly 10% of its staff.

News for Tilray Brands Stock (TLRY)